IL85603A - Synergistic compositions of interleukin-2 and mismatched double- stranded rna - Google Patents

Synergistic compositions of interleukin-2 and mismatched double- stranded rna

Info

Publication number
IL85603A
IL85603A IL85603A IL8560388A IL85603A IL 85603 A IL85603 A IL 85603A IL 85603 A IL85603 A IL 85603A IL 8560388 A IL8560388 A IL 8560388A IL 85603 A IL85603 A IL 85603A
Authority
IL
Israel
Prior art keywords
lymphokines
interleukin
dsrna
human
stranded rna
Prior art date
Application number
IL85603A
Other languages
English (en)
Other versions
IL85603A0 (en
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of IL85603A0 publication Critical patent/IL85603A0/xx
Publication of IL85603A publication Critical patent/IL85603A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
IL85603A 1987-03-03 1988-03-01 Synergistic compositions of interleukin-2 and mismatched double- stranded rna IL85603A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2136887A 1987-03-03 1987-03-03

Publications (2)

Publication Number Publication Date
IL85603A0 IL85603A0 (en) 1988-08-31
IL85603A true IL85603A (en) 1993-05-13

Family

ID=21803798

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85603A IL85603A (en) 1987-03-03 1988-03-01 Synergistic compositions of interleukin-2 and mismatched double- stranded rna

Country Status (19)

Country Link
EP (1) EP0281380B1 (fr)
JP (1) JPH0713024B2 (fr)
KR (1) KR960008009B1 (fr)
CN (1) CN1054509C (fr)
AT (1) ATE130760T1 (fr)
AU (2) AU1256588A (fr)
CA (1) CA1336810C (fr)
DE (1) DE3854726T2 (fr)
DK (1) DK113188A (fr)
ES (1) ES2082749T3 (fr)
FI (1) FI880961A7 (fr)
IE (1) IE75895B1 (fr)
IL (1) IL85603A (fr)
NO (1) NO880946L (fr)
NZ (1) NZ223720A (fr)
PH (1) PH24467A (fr)
PT (1) PT86879B (fr)
RU (1) RU1836103C (fr)
ZA (1) ZA881512B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA881639B (en) * 1987-03-23 1989-02-22 Hem Res Inc Treatment of human viral infection by dsrna combined with viral inhibitors
ES2076259T3 (es) * 1989-06-30 1995-11-01 American Cyanamid Co Metodo para el tratamiento de enfermedades infecciosas activando celulas fagociticas en animales.
TW589189B (en) 1997-08-04 2004-06-01 Scras Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis
FR2768344B1 (fr) * 1997-08-26 2001-02-16 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale
FR2768345B1 (fr) * 1997-09-17 2001-05-04 Scras Produit comprenant au moins un arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique dans le traitement d'une maladie virale, notamment d'une hepatite virale
FR2766715B1 (fr) * 1997-08-04 2001-02-16 Scras Produit comprenant au moins de l'arn double brin en association avec au moins un agent anti-viral pour une utilisation therapeutique simultanee, separee ou etalee dans le temps, dans le traitement d'une maladie virale
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
AU776150B2 (en) 1999-01-28 2004-08-26 Medical College Of Georgia Research Institute, Inc. Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded RNA
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US20020132257A1 (en) 2001-01-31 2002-09-19 Tony Giordano Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
WO2006054129A1 (fr) * 2004-11-19 2006-05-26 Institut Gustave Roussy Traitement ameliore du cancer par arn double brin
EP2116602A1 (fr) 2008-05-07 2009-11-11 Institut Gustave Roussy Combinaison de produits pour traiter le cancer
WO2011109833A2 (fr) 2010-03-05 2011-09-09 President And Fellows Of Harvard College Compositions de cellules dendritiques induites et utilisations associées
CN106794246B (zh) 2014-08-08 2021-10-15 OncoQuest制药有限公司 肿瘤抗原特异性抗体和tlr3刺激以增强检查点干扰癌症疗法的性能
TW202308629A (zh) 2021-04-28 2023-03-01 法商Ｅｎｙｏ製藥公司 使用fxr激動劑作為組合治療以增強tlr3激動劑之療效

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (fr) * 1982-09-16 1989-07-19 Hem Research, Inc. Effet antinéoplastiques des acides ds-ribonucléiques sur les cellules des tumeurs
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
EP0281380A3 (en) 1989-09-27
AU1256588A (en) 1988-09-01
NO880946L (no) 1988-09-05
CN1054509C (zh) 2000-07-19
PT86879B (pt) 1992-05-29
EP0281380A2 (fr) 1988-09-07
JPS63295514A (ja) 1988-12-01
DE3854726T2 (de) 1996-07-25
RU1836103C (ru) 1993-08-23
NO880946D0 (no) 1988-03-03
FI880961L (fi) 1988-09-04
KR880010776A (ko) 1988-10-24
IL85603A0 (en) 1988-08-31
AU1618992A (en) 1992-08-06
NZ223720A (en) 1991-07-26
IE880588L (en) 1988-09-03
DE3854726D1 (de) 1996-01-11
PT86879A (pt) 1988-04-01
IE75895B1 (en) 1997-09-24
ATE130760T1 (de) 1995-12-15
CN1032296A (zh) 1989-04-12
ES2082749T3 (es) 1996-04-01
JPH0713024B2 (ja) 1995-02-15
FI880961A0 (fi) 1988-03-02
PH24467A (en) 1990-07-18
FI880961A7 (fi) 1988-09-04
ZA881512B (en) 1988-11-30
CA1336810C (fr) 1995-08-29
DK113188A (da) 1988-09-04
KR960008009B1 (ko) 1996-06-19
DK113188D0 (da) 1988-03-02
EP0281380B1 (fr) 1995-11-29

Similar Documents

Publication Publication Date Title
ZA881512B (en) Synergistic interplay of lymphokines and double-stranded rnas
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
NZ226005A (en) Covalent conjugates of a human cytokine and a human immunoglobulin, processes for their manufacture and pharmaceutical compositions thereof
AU1256288A (en) Treatment of human viral infections by dsrna combined with viral inhibitors
MY104069A (en) Therapeutic nucleosides
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
ES2099059T3 (es) Una composicion para promover el secuestro y extraccion del cuerpo de un animal de macromoleculas.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
EP0306347A3 (en) Diagnosis and treatment of double-stranded rna deficiency states
ES2094702B1 (es) Composiciones farmaceuticas para la prevencion y el tratamiento de enfermedades cancerosas y procedimiento para su preparacion.
CA2002648A1 (fr) Derives 2'-halogenomethylidene, 2'-ethenylidene et 2'-ethynyle de cytidine, uridine et guanosine
WO1999024077A3 (fr) Compositions et procedes d'administration ciblee de facteurs
BG100599A (en) Antiviral form and therapeutical method
ES2036526T3 (es) Composiciones de interferon.
BR9007741A (pt) Protecao contra estados de choque subsequentes a lesoes por rnas de duplo filamento
EP0325018A3 (fr) RNase L inhibiteur comme marqueur pour des infections virales
EP0285263A3 (en) Activated rnase l as a marker for virus infections
DE69106877D1 (de) Aus blaualgen hergestellte biologisch aktive verbindungen.
MY111746A (en) Therapeutic nucleosides.
EP1013763A4 (fr) INTERLEUKINE 18 CANINE, INTERLEUKINE-1 $g(b)-CONVERTASE CANINE, SEQUENCES D'ADN CODANT CETTE ENZYME, PROCEDE DE PRODUCTION DE L'INTERLEUKINE 18, ET REMEDES CONTRE LES MALADIES IMMUNOLOGIQUES CHEZ LE CHIEN
DE3462891D1 (en) New pyrimidine derivatives endowed with antiviral activity
Kohl Additive effects of acyclovir and immune transfer in neonatal herpes simplex virus infection in mice
SU1727820A1 (ru) Способ стимул ции сперматогенеза у быков
Stebbing Effects of treatments with single-stranded polynucleotides on spontaneous AKR mouse leukaemia
JO1708B1 (en) The use of trinitrobenzene or cochineal acid in the treatment of cancer or genital diseases

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees